cardiovascular benefits of glp-1 agonists and drawbacks receptor agonist use. Abbreviations: GLP-1 receptor agonists improve cardiovascular
Description
The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease
no major safety concerns were observed
Understand about the investigational Alluvi Retatrutide 40 mg injection a GLP-1 + GIP + Glucagon triple-agonist studied for obesity
Yale Medicine experts explain who qualifies, who can prescribe, and what to expect.
Ozempic alternatives in the GLP-1 family offer effective weight loss pathways
It is the first GLP-1 pill approved for losing excess weight.
